Kangmei Pharmaceutical Co., Ltd. (600518.SS) SHH

1.93

+0(+0.00%)

Updated at December 25 03:00PM

Currency In CNY

Valuation

Market Cap33.44B
Enterprise Value32.57B
P/E Ratio1,603.91
PEG Ratio11.46
Price/Sales Ratio5.07
Price/Book Ratio3.71
Enterprise/Revenue4.89
Enterprise/EBITDA-305.53

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets0
Return On Equity0

Income Statement

Revenue5.19B
Revenue/Share0.38
Gross Profit653.37M
EBITDA-131.8M
Net Income8.57M
Diluted EPS0

Balance Sheet

Total Cash1.18B
Total Cash/Share0.09
Total Debt193.28M
Total Debt/Equity0.03
Current Ratio1.21
Book Value Per Share0.52

Price History

52-Week Change-19.58
52-Week High2.47
52-Week Low1.81
Moving Average 50 Days2.02
Moving Average 200 Days2.02

Statistics

Average Volume202.86M
Shares Outstanding13.83B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.05
Last Split Factor2:1
Last Split DateJune 16, 2015